Trial Profile
A 21-Day, Randomized, Controlled Study to Evaluate the Irritation Potential of Abametapir Lotion in Healthy Volunteers, Using a Cumulative Irritant Patch Test Design
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jul 2021
Price :
$35
*
At a glance
- Drugs Abametapir (Primary) ; Sodium chloride; Sodium lauril-sulfate
- Indications Pediculosis
- Focus Adverse reactions
- Sponsors Dr Reddys Laboratories; Hatchtech
- 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2014 New trial record